HealthCor Management, L.P.

CIK 0001343781

3 SPACs with a current declared position, filed between Feb 14, 2022 and Feb 14, 2023. 0 of them were re-affirmed in the last 12 months. The rest are the filer’s last word on a position, not proof it is still held: an amendment is only required on a material change, so a fund that sells below 5% may never file again.

This filer has not filed a Schedule 13 on any SPAC since Feb 14, 2023. Read the page below as a record of what was declared, not as a register of what is held.

SPACs declared

every position whose latest statement stands — the record

Re-affirmed in 12 months

filed inside 365 days — what a reader means by "owns"

Still live

positions in SPACs still searching or in an announced deal

Median stake

0.0%

no percentage stated on the cover pages

3 passive (13G)36 superseded statements on file

Positions

one row per SPAC — every figure read from the accession in the Source column

3 of 3 shown · 3 positions have not been amended in over a year

	SPAC			Voting	Dispositive			Source
RACB	Research Alliance Corp. II11 reporting persons on this schedule	4.0%	625,133	0 / 625,133	0 / 625,133	Liquidated	Feb 14, 2023Stale	SC 13G/A0001104659-23-020382 14 earlier statements
ARYD	ARYA Sciences Acquisition Corp IV11 reporting persons on this schedule	0.0%	0	0 / 0	0 / 0	Closed (deSPAC)	Feb 14, 2022Stale	SC 13G/A0001104659-22-021993 11 earlier statements
MSAC	Medicus Sciences Acquisition Corp.11 reporting persons on this schedule	0.0%	0	0 / 0	0 / 0	Liquidated	Feb 14, 2022Stale	SC 13G/A0001104659-22-021996 11 earlier statements

36 superseded statements (newest 4 shown)

An amendment replaces a stake as current; it never erases the record of it. These are the earlier statements, each with the accession that replaced it — kept because “what did this filer say in 2022” is a different question from “what does it say now”, and only the second one has an answer above.

RACB Research Alliance Corp. II8.6% · SC 13G/A Feb 14, 2022replaced Feb 14, 2023 by 0001104659-23-020382
RACB Research Alliance Corp. II6.5% · SC 13G Mar 29, 2021replaced Feb 14, 2022 by 0001104659-22-021997
ARYD ARYA Sciences Acquisition Corp IV7.4% · SC 13G Mar 8, 2021replaced Feb 14, 2022 by 0001104659-22-021993
MSAC Medicus Sciences Acquisition Corp.8.5% · SC 13G Feb 26, 2021replaced Feb 14, 2022 by 0001104659-22-021996

Reporting persons on this filer's schedules

one filer, several names — collapsed once, shown in full

A joint Schedule 13 names every person who beneficially owns the shares — the management company, the funds it advises, the general partner and often the individual who controls all three. They report the same shares. Counting them separately would publish this filer’s footprint two or three times over, so they are counted once, under CIK 0001343781. This filer has named 11 of them across the schedules in the table above:

Arthur Cohen
HealthCor Associates
HealthCor Group
HealthCor Management
HealthCor Offshore GP
HealthCor Offshore II GP
HealthCor Offshore Master Fund
HealthCor Sanatate Offshore Master Fund
HealthCor Therapeutics GP
HealthCor Therapeutics Master Fund
Joseph Healey

Appears alongside

other filers with a current declared position in the same SPACs

Co-occurrence in the disclosure record, and nothing more. It is not evidence of a group, an agreement or acting in concert — filers who act as a group say so on the cover page and file a 13D. Two arbitrage funds above 5% in the same shell is the ordinary shape of this market. The second number restricts both sides to statements filed in the last 12 months, because a 2021 stake beside a 2026 one is two facts about two different years.

Every percentage above is the one printed on the cover page of the filing cited beside it — a percentage of the shares outstanding on that date. A SPAC’s float collapses at each redemption, so two of these percentages are percentages of two different companies and they do not add. Rows are one per SPAC: where a joint schedule names several reporting persons, the largest single figure is shown rather than their sum, because a manager and the funds it advises beneficially own the same shares. Nothing on this page is derived from a 13F, a vendor holdings file or a press release. See how this is built.